Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Link opens in a new tab
Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Fluconazole-resistant candida albicans vulvovaginitis
Dror Marchaim
, Leslie Lemanek
, Suchitha Bheemreddy
, Keith S. Kaye
, Jack D. Sobel
*
*
Corresponding author for this work
Wayne State University
Research output
:
Contribution to journal
›
Article
›
peer-review
185
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Fluconazole-resistant candida albicans vulvovaginitis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Fluconazole
100%
Fluconazole-resistant Candida Albicans
100%
Vulvovaginitis
100%
Vaginitis
75%
Fluconazole Resistance
50%
C.albicans
37%
Microgram
37%
Minimum Inhibitory Concentration
25%
Candida Albicans (C. albicans)
12%
Patient-completed
12%
Comorbidity
12%
Behavioral Characteristics
12%
Drug Resistance
12%
Risk Factors
12%
Socioeconomic Status
12%
Formal Education
12%
Antimicrobial
12%
Recurrence Rate
12%
Maintenance Therapy
12%
White Women
12%
New Therapeutic Modalities
12%
Emerging Problems
12%
Risk Analysis
12%
Defined Daily Dose
12%
Refractory Disease
12%
Broth Microdilution
12%
Resistance Analysis
12%
Wayne State University
12%
Pharmacology, Toxicology and Pharmaceutical Science
Candida Albicans
100%
Fluconazole
100%
Vulvovaginitis
100%
Vaginitis
46%
Minimum Inhibitory Concentration
15%
Cohort Study
7%
Drug Resistance
7%
Recurrence Risk
7%
Defined Daily Dose
7%
Comorbidity
7%
Diseases
7%
Medicine and Dentistry
Fluconazole
100%
Vulvovaginitis
100%
Vaginitis
46%
Low Drug Dose
7%
Therapeutic Modality
7%
Socioeconomic Status
7%
Cohort Analysis
7%
Drug Resistance
7%
Recurrence Risk
7%
Maintenance Therapy
7%
Comorbidity
7%
Diseases
7%